Personal profile
Research interests
Novel therapies for cystic fibrosis, complications of cystic fibrosis and its treatments.
Clinical interests
Pediatric pulmonology, cystic fibrosis.
Available to Mentor:
- Undergraduate Students
- Post-Baccalaureate Students
- PhD Students
- Health Professions (Medical, OT, PT, Dental, Audiology, etc.) Students
- Postdocs
- Residents and Fellows
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Clinical Observations in Patients With Cystic Fibrosis-Related Diabetes and Self-Reported Ototoxicity Symptoms
Nichols, N., Rubenstein, R. C., Kelly, A., Vachhani, J. J., Echaluse, M. V. & Garinis, A. C., Mar 2024, In: American Journal of Audiology. 33, 1, p. 283-291 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Early-phase insulin secretion during mixed-meal tolerance testing predicts β-cell function and secretory capacity in cystic fibrosis
Sheikh, S., Stefanovski, D., Kilberg, M. J., Hadjiliadis, D., Rubenstein, R. C., Rickels, M. R. & Kelly, A., 2024, In: Frontiers in Endocrinology. 15, 1340346.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Preservation of β-cell Function in Pancreatic Insufficient Cystic Fibrosis With Highly Effective CFTR Modulator Therapy
Flatt, A. J., Sheikh, S., Peleckis, A. J., Alvarado, P., Hadjiliadis, D., Stefanovski, D., Gallop, R. J., Rubenstein, R. C., Kelly, A. & Rickels, M. R., Jan 1 2024, In: Journal of Clinical Endocrinology and Metabolism. 109, 1, p. 151-160 10 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Link opens in a new tab Scopus citations -
Quantification of Enteric Dysfunction in Cystic Fibrosis: Inter- and Intraindividual Variability
Duckworth, L. A., Sutton, K. A., Shaikh, N., Wang, J., Hall-Moore, C., Holtz, L. R., Tarr, P. I. & Rubenstein, R. C., Feb 2024, In: Journal of Pediatrics. 265, 113800.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials
VX18-121-101, VX18-561-101 Study Groups, Rubenstein, R. C. & Rosenbluth, D. B., Jun 2023, In: The Lancet Respiratory Medicine. 11, 6, p. 550-562 13 p.Research output: Contribution to journal › Article › peer-review
Open Access68 Link opens in a new tab Scopus citations